Literature DB >> 20692690

The US Food and Drug Administration and long-acting beta2-agonists: the importance of striking the right balance between risks and benefits of therapy?

Robert F Lemanske, William W Busse.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20692690     DOI: 10.1016/j.jaci.2010.05.039

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  5 in total

1.  Sir David Jack: an extraordinary drug discoverer and developer.

Authors:  Clive Page; Patrick Humphrey
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

2.  International consensus on (ICON) pediatric asthma.

Authors:  N G Papadopoulos; H Arakawa; K-H Carlsen; A Custovic; J Gern; R Lemanske; P Le Souef; M Mäkelä; G Roberts; G Wong; H Zar; C A Akdis; L B Bacharier; E Baraldi; H P van Bever; J de Blic; A Boner; W Burks; T B Casale; J A Castro-Rodriguez; Y Z Chen; Y M El-Gamal; M L Everard; T Frischer; M Geller; J Gereda; D Y Goh; T W Guilbert; G Hedlin; P W Heymann; S J Hong; E M Hossny; J L Huang; D J Jackson; J C de Jongste; O Kalayci; N Aït-Khaled; S Kling; P Kuna; S Lau; D K Ledford; S I Lee; A H Liu; R F Lockey; K Lødrup-Carlsen; J Lötvall; A Morikawa; A Nieto; H Paramesh; R Pawankar; P Pohunek; J Pongracic; D Price; C Robertson; N Rosario; L J Rossenwasser; P D Sly; R Stein; S Stick; S Szefler; L M Taussig; E Valovirta; P Vichyanond; D Wallace; E Weinberg; G Wennergren; J Wildhaber; R S Zeiger
Journal:  Allergy       Date:  2012-06-15       Impact factor: 13.146

Review 3.  Advancing asthma care: the glass is only half full!

Authors:  Stanley J Szefler
Journal:  J Allergy Clin Immunol       Date:  2011-07-27       Impact factor: 10.793

Review 4.  Advances in pediatric asthma in 2010: addressing the major issues.

Authors:  Stanley J Szefler
Journal:  J Allergy Clin Immunol       Date:  2011-01       Impact factor: 10.793

Review 5.  Asthma in children and adolescents: a comprehensive approach to diagnosis and management.

Authors:  Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.